View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Cosmin Filker ... (+2)
  • Cosmin Filker
  • Matthias Greiffenberger
7V0 DARWIN AG

Researchstudie (Initial Coverage) - DARWIN AG - 04.02.2026

Fokussierte HealthTech-Wachstumsstory mit starker Bilanz und skalierbarem Kerngeschäft Die DARWIN AG ist ein in München ansässiges Unternehmen, das sich auf DNA-basierte Analysen und darauf aufbauende personalisierte Gesundheits- und Lifestyle-Produkte spezialisiert hat. Ihr Kerngeschäft umfasst genetische Analysen sowie die Entwicklung, Herstellung und den Vertrieb individualisierter Nahrungsergänzungsmittel und Kosmetikprodukte. Das vertikal integrierte Modell umfasst genetische Analysen, d...

02/04/26 February 4, 2026 40 DE
Ahmed Ben Salem ... (+3)
  • Ahmed Ben Salem
  • Emira Sagaama
  • Oddo Sustainability Team
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
VAC PIERRE & VACANCES SA
BIO BB BIOTECH AG
STF STEF
ITP INTERPARFUMS
SWP SWORD GROUP SE
GLO GL EVENTS SA
ACX ACERINOX SA
EBRO EBRO FOODS SA
ENI ENI S.P.A.
REP REPSOL SA
AALB AALBERTS N.V.
ARG ARGAN SA
FLU FLUGHAFEN WIEN AG
SIFG SIF HOLDING NV
SFSN SFS GROUP AG
BP. BP P.L.C.
FAST FASTNED
AZE AZELIS GROUP NV
SHEL SHELL PLC
7V0 DARWIN AG
ARYN ARYZTA AG
01/23/26 January 23, 2026 1 EN
Ahmed Ben Salem ... (+3)
  • Ahmed Ben Salem
  • Emira Sagaama
  • Oddo Sustainability Team
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
VAC PIERRE & VACANCES SA
BIO BB BIOTECH AG
STF STEF
ITP INTERPARFUMS
SWP SWORD GROUP SE
GLO GL EVENTS SA
ACX ACERINOX SA
EBRO EBRO FOODS SA
ENI ENI S.P.A.
REP REPSOL SA
AALB AALBERTS N.V.
ARG ARGAN SA
FLU FLUGHAFEN WIEN AG
SIFG SIF HOLDING NV
SFSN SFS GROUP AG
BP. BP P.L.C.
FAST FASTNED
AZE AZELIS GROUP NV
SHEL SHELL PLC
7V0 DARWIN AG
ARYN ARYZTA AG
01/23/26 January 23, 2026 1 FR
Klaus Breitenbach
  • Klaus Breitenbach
PREMIUM
7V0 DARWIN AG

Darwin AG : Personalised lifestyle products based on DNA

Darwin is a European healthcare and biotechnology company, focused on human genetics. The genetic analyses carried out in its own laboratory are used in diagnostics, therapy and prevention of diseases as well as in the production of individually designed nutritional supplements and cosmetics. Its business is divided into diagnostics & personalised products (c. 30% of 2024 total revenues) and drug import & medical devices (c.70%) as well as minority investments. The company is growing rapidly and...

01/23/26 January 23, 2026 1 EN
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch